You are here
Publications
Popular Publications
Management of Confidential Jurisdictional Information Protocol
22 April 2021The Management of Confidential Jurisdictional Information Protocol outlines the limited and prescribed purpose for which the Independent Hospital Pricing Authority can collect and analyse confidential jurisdictional information and the processes and controls in place to prevent unauthorised access and disclosure to unauthorised parties.
Assessing Materiality of Changes Proposed to the National Pricing Model
22 April 2021The Assessing Materiality of Changes Proposed to the National Pricing Model document outlines the process the Independent Hospital Pricing Authority follows when assessing the materiality of proposed refinements to the national pricing model, such as new adjustments for specific cohorts of patients or the application of modified pricing approaches.
Data Access and Release Policy
22 April 2021The Independent Hospital Pricing Authority (IHPA) is responsible for relevant data collections to enable activity based funding. IHPA’s Data Access and Release Policy outlines the principles and processes adopted by IHPA in the discretionary access and release of data collected under the National Health Reform Act 2011. The Policy provides guidance as to how IHPA will determine whether to release data.
National Pricing Model Stability Policy
22 April 2021This Policy outlines the processes by which the Independent Hospital Pricing Authority stabilises volatility in the year-on-year price weights and adjustments to ensure funding stability and predictability for local hospital networks and hospital managers.
IHPA Work Program 2020–21
29 June 2020As prescribed in Section 225 of the National Health Reform Act 2011, the objectives of the IHPA Work Program are to:
- set out IHPA’s work program for the coming year; and
- invite interested persons (including states and territories) to make submissions to the Pricing Authority about the Work Program up to 30 days after publication.
An extract of Section 225 of the Act is attached at Appendix 1.
Chimeric antigen receptor T cell therapy (CAR-T cell): guidelines for costing, counting and reconciliation of funding
18 June 2020The guidelines set out the scope, funding, costing, counting and reconciliation of funding for the chimeric antigen receptor T cell therapy (CAR-T cell) immunotherapy program using the Novartis CAR-T product Kymriah. The CAR-T program is for paediatric and young adults (up to 25 years) with Acute Lymphoblastic Leukaemia (ALL) who relapse or do not respond to initial therapy.
IHPA Data Access and Release Policy
28 May 2020IHPA is responsible for relevant data collections to enable activity based funding. IHPA’s Data Access and Release Policy outlines the principles and processes adopted by IHPA in the discretionary access and release of data collected under the National Health Reform Act 2011. The Policy provides guidance as to how IHPA will determine whether to release data.
Management of Confidential Jurisdictional Information Protocol
28 May 2020The purpose of the Management of Confidential Jurisdictional Information Protocol is to advise jurisdictions of the processes and controls adopted by IHPA in managing confidential jurisdictional information as part of its rolling Three Year Data Plan.
General List of In-Scope Public Hospital Services Eligibility Policy
28 May 2020Each year, IHPA publishes the General List of In-Scope Public Hospital Services (the General List) as part of the National Efficient Price Determination.
The General List defines public hospital services eligible for Commonwealth funding, except where funding is otherwise agreed between the Commonwealth and a state or territory.
National Pricing Model Stability Policy
9 December 2019The purpose of the Policy is to outline the processes by which IHPA adjusts for instability in the year-on-year price weights and adjustments.
Assessing Materiality of Changes Proposed to the National Pricing Model
9 December 2019The purpose of the Assessing Materiality of Changes Proposed to the National Pricing Model document is to outline the process IHPA follows when assessing the materiality of proposed changes to the national pricing models such as the introduction of new adjustments or alternative pricing policy approaches.
Value-based health care
3 December 2019There is a growing discussion in Australia and internationally about the need to increase focus on delivering value-based health care with a focus on patient outcomes and experience.
IHPA’s Pricing Guidelines and the National Health Reform Agreement include provisions for IHPA to consider the impact on its work of evidence‑based, effective new technologies and innovations in models of health care.
IHPA Data Access and Release Policy
14 August 2019The IHPA Data Access and Release Policy (formerly Information Release Policy) outlines the principles and processes adopted by IHPA in the discretionary access and release of data under the National Health Reform Agreement and the National Health Reform Act 2011.
Management of Confidential Jurisdictional Information Protocol
8 July 2019The purpose of the Management of Confidential Jurisdictional Information Protocol is to advise jurisdictions of the processes and controls adopted by IHPA in managing confidential jurisdictional information as part of its rolling Three Year Data Plan.
IHPA Work Program 2019–20
27 June 2019As prescribed in Section 225 of the National Health Reform Act 2011, the objectives of the IHPA Work Program are to: